
Sign up to save your podcasts
Or


Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug prices as well as supply chain security (30:10).
By Chad P. Bown4.8
313313 ratings
Thomas J. Bollyky (Council on Foreign Relations) joins to explain the problems facing the US pharmaceutical market, the Trump administration's new tariffs and pricing deal with the United Kingdom, and the impact on American drug prices as well as supply chain security (30:10).

4,129 Listeners

2,004 Listeners

355 Listeners

2,448 Listeners

604 Listeners

100 Listeners

608 Listeners

207 Listeners

721 Listeners

141 Listeners

16,327 Listeners

267 Listeners

359 Listeners

478 Listeners

141 Listeners